SG11201602868WA - Probiotic stabilization - Google Patents

Probiotic stabilization

Info

Publication number
SG11201602868WA
SG11201602868WA SG11201602868WA SG11201602868WA SG11201602868WA SG 11201602868W A SG11201602868W A SG 11201602868WA SG 11201602868W A SG11201602868W A SG 11201602868WA SG 11201602868W A SG11201602868W A SG 11201602868WA SG 11201602868W A SG11201602868W A SG 11201602868WA
Authority
SG
Singapore
Prior art keywords
probiotic
stabilization
probiotic stabilization
Prior art date
Application number
SG11201602868WA
Other languages
English (en)
Inventor
Bolivar Cevallos
Bhavini Shah
Juan M Gonzalez
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43756845&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201602868W(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of SG11201602868WA publication Critical patent/SG11201602868WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
SG11201602868WA 2009-09-20 2014-11-06 Probiotic stabilization SG11201602868WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/563,157 US20110070334A1 (en) 2009-09-20 2009-09-20 Probiotic Stabilization
US14/098,568 US20140093613A1 (en) 2009-09-20 2013-12-06 Probiotic stabilization
PCT/US2014/064315 WO2015084531A1 (fr) 2009-09-20 2014-11-06 Stabilisation de probiotique

Publications (1)

Publication Number Publication Date
SG11201602868WA true SG11201602868WA (en) 2016-05-30

Family

ID=43756845

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602868WA SG11201602868WA (en) 2009-09-20 2014-11-06 Probiotic stabilization

Country Status (23)

Country Link
US (3) US20110070334A1 (fr)
EP (2) EP2477638B1 (fr)
JP (1) JP6240386B2 (fr)
KR (1) KR20120068851A (fr)
CN (4) CN107594537A (fr)
AR (1) AR098598A1 (fr)
AU (2) AU2010295508B2 (fr)
BR (1) BR112012006220A2 (fr)
CA (2) CA2772534A1 (fr)
CO (1) CO6511231A2 (fr)
EC (1) ECSP12011820A (fr)
ES (1) ES2683310T3 (fr)
IN (1) IN2012DN01440A (fr)
MX (2) MX343446B (fr)
MY (2) MY171199A (fr)
NZ (1) NZ598520A (fr)
PE (1) PE20121503A1 (fr)
PH (1) PH12016500689A1 (fr)
PL (1) PL2477638T3 (fr)
RU (1) RU2012115658A (fr)
SG (1) SG11201602868WA (fr)
TW (2) TWI621707B (fr)
WO (2) WO2011035093A1 (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1973406B1 (fr) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation Véhicule de délivrance pour bactéries probiotiques, comprenant une matrice sèche en polysaccharides, saccharides et polyols sous forme de verre
CA2673120C (fr) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation Produit alimentaire sec contenant un probiotique vivant
ES2908047T3 (es) 2009-03-27 2022-04-27 Intervet Int Bv Vacunas en micropartículas para la vacunación oral o nasal y el refuerzo de animales incluidos los peces
NZ597053A (en) 2009-05-26 2014-02-28 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
EP2529004B1 (fr) 2010-01-28 2017-06-07 Advanced Bionutrition Corporation Composition vitreuse sèche comprenant un matériau bioactif
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
RU2573324C2 (ru) 2010-08-13 2016-01-20 Эдванст Байоньютришн Корпорейшн Стабилизирующая композиция для сухого хранения биологических материалов (варианты)
US20120135103A1 (en) * 2010-11-30 2012-05-31 Mead Johnson Nutrition Company Staged Infant Feeding Regimen To Promote Healthy Development And Growth
MX352677B (es) 2011-06-20 2017-12-04 Heinz Co Brands H J Llc Composiciones probioticas y metodos.
IN2014CN02447A (fr) 2011-06-30 2015-08-07 Chr Hansen As
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
SG11201403653VA (en) * 2011-12-30 2014-07-30 Abbott Lab Concentrated low water activity liquid human milk fortifier including extensively hydrolyzed protein
NZ628912A (en) 2012-03-23 2016-06-24 Advanced Bionutrition Corp Stabilizing composition for biological materials
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
BR112015011759A2 (pt) * 2012-11-29 2017-07-11 Nestec Sa composição simbiótica e uso da mesma
PT2994150T (pt) 2013-05-10 2019-06-14 Heinz Co Brands H J Llc Probióticos e métodos de utilização
MY182613A (en) * 2013-12-06 2021-01-27 Mjn Us Holdings Llc Probiotic stabilization
US10624934B2 (en) 2014-03-06 2020-04-21 Research Institute At Nationwide Children's Hospital Prebiotic formulations
EP3113630B1 (fr) * 2014-03-06 2019-12-11 The Research Institute at Nationwide Children's Hospital Préparations probiotiques et méthodes d'utilisation associées
WO2015140299A1 (fr) * 2014-03-20 2015-09-24 Universiteit Antwerpen Probiotiques naso-oro-pharyngés
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
KR101640744B1 (ko) * 2014-05-07 2016-07-19 일동제약주식회사 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도
US10195237B2 (en) 2015-03-16 2019-02-05 Imagilin Technology Llc Compositions and methods for treating inflammatory related diseases or conditions using Pediococcus acidilactici probiotics
US10946050B2 (en) 2015-03-16 2021-03-16 Imagilin Technology Llc Compositions comprising probiotics and methods of use thereof
US20170020165A1 (en) * 2015-07-22 2017-01-26 48th Parallel Incorporated Iso-alpha acid tinctures and carbonated beverage compositions including the same
WO2017019273A1 (fr) * 2015-07-29 2017-02-02 Advanced Bionutrition Corporation Compositions probiotiques sèches stables pour des utilisations diététiques
EP3365027B1 (fr) 2015-10-14 2022-03-30 Research Institute at Nationwide Children's Hospital Anticorps spécifiques interférant avec hu et leur utilisation comme inhibiteur de biofilm
WO2017083549A1 (fr) * 2015-11-10 2017-05-18 Probiotech Llc Systèmes d'administration de probiotiques
EP3167895A1 (fr) * 2015-11-10 2017-05-17 University College Dublin Complément alimentaire contenant du bêta-glucane et d'hydrolysat de caséine pour améliorer la santé et la performance de croissance chez un mammifère
CN109803666A (zh) * 2015-11-30 2019-05-24 医迈霖科技公司 包括益生菌的组合物及其使用方法
AU2016365214B2 (en) 2015-12-04 2021-02-25 Advanced Bionutrition Corp. Stable dry compositions having no or little sugars
TWI587863B (zh) * 2016-01-29 2017-06-21 Grape King Inc A probiotic entrapping particle
CN105661017A (zh) * 2016-02-03 2016-06-15 程雪娇 一种牲畜饲料及制备方法
US9855305B2 (en) 2016-03-29 2018-01-02 Companion Therapeutics Llc Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors
EP3287145A1 (fr) * 2016-08-26 2018-02-28 DuPont Nutrition Biosciences ApS Utilisation de maltodextrine comme excipient
CN107744017A (zh) * 2017-06-27 2018-03-02 中食月太(北京)健康科技有限公司 一种含水解酪蛋白的益生菌固体饮料及其制备方法
CL2017003444A1 (es) * 2017-12-28 2018-05-18 Univ Santiago Chile Aditivo probiótico para alimento sólido deshidratado, preferentemente, cereal; método de preparación de dicho aditivo y alimento sólido deshidratado que lo contiene
US20190208807A1 (en) * 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
KR20200125966A (ko) 2018-03-15 2020-11-05 유니버시티 오브 써던 캘리포니아 염증 및 ibd 병리의 역전을 촉진하는, 물만 섭취하는 금식이 아닌 금식 모방 식이요법 (fmd)
US20190388344A1 (en) 2018-06-22 2019-12-26 Probiotech Llc Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
CN109288069A (zh) * 2018-11-29 2019-02-01 无锡市人民医院 一种可减少腹泻的肠内营养制剂
CN109517759A (zh) * 2018-12-04 2019-03-26 山西大学 一种适于肠道定植、提高消化率和免疫力的枯草芽孢杆菌制剂及其制备方法
EP3930748A1 (fr) * 2019-03-01 2022-01-05 GlaxoSmithKline Biologicals S.A. Compositions nutraceutiques
KR102009731B1 (ko) * 2019-04-15 2019-08-12 주식회사 쎌바이오텍 단백질 가수분해물을 이용한 단백질-다당류 이중코팅 유산균의 제조방법
CN112189850A (zh) * 2020-09-17 2021-01-08 合生元（广州）健康产品有限公司 益生元在促进胃肠道中益生菌存活的应用
KR102273663B1 (ko) * 2020-10-29 2021-07-05 주식회사 에치와이 코팅 프로바이오틱스 및 이를 포함하는 식품 조성물, 이의 제조방법
WO2022112551A1 (fr) * 2020-11-30 2022-06-02 Chr. Hansen A/S Procédé de préparation de produits bactériens
CN116782779A (zh) * 2021-02-10 2023-09-19 帝斯曼知识产权资产管理有限公司 粉末组合物(i)
JP2024506466A (ja) * 2021-02-10 2024-02-14 ディーエスエム アイピー アセッツ ビー．ブイ． 粉末状組成物（ｉｉ）
CN113116941B (zh) * 2021-03-08 2023-05-12 山东晶辉生物技术有限公司 一种可缓解2型糖尿病的益生菌、益生元复合制剂及其制备方法
WO2024052310A1 (fr) * 2022-09-09 2024-03-14 Dsm Ip Assets B.V. Poudre de vitamine liposoluble pour fortifier des produits alimentaires
WO2024076586A2 (fr) * 2022-10-03 2024-04-11 Vitakey Inc. Compositions probiotiques encapsulées dans des lipides

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443540A (en) * 1980-05-09 1984-04-17 University Of Illinois Foundation Protein hydrolysis
US4545933A (en) * 1980-08-20 1985-10-08 Ernster John H Hydrolyzed protein composition and process used in preparation thereof
US4377601A (en) * 1981-09-04 1983-03-22 Miller Brewing Company Method of removing hulls from brewer's spent grain
US4713341A (en) * 1983-09-16 1987-12-15 Bily Robert Raymond Starter cultures of improved activity for dairy products and process of making same
JPS60176549A (ja) * 1984-02-22 1985-09-10 Nisshin Oil Mills Ltd:The たん白分解物の製造法
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
GR861162B (en) * 1985-05-06 1986-09-01 Unilever Nv Improved protein hydrolysate
EP0259739A1 (fr) 1986-09-10 1988-03-16 Rhone-Poulenc Inc. Stabilité de cultures lyophilisées
EP0361595B1 (fr) * 1988-09-26 1993-11-18 Unilever N.V. Procédé de préparation d'un hydrolysat de protéines
MY109493A (en) * 1989-07-07 1997-02-28 Nestle Sa Protein hydrolysis.
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
AU661297B2 (en) * 1991-01-24 1995-07-20 Martek Corporation Microbial oil mixtures and uses thereof
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
US5374567A (en) * 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
CZ300387B6 (cs) 1997-07-05 2009-05-06 Societe Des Produits Nestle S. A. Použití bakterií Lactobacillus
US6221423B1 (en) * 1998-04-13 2001-04-24 Protein Technologies Int'l Inc. Short-chained peptide material
AU6053600A (en) * 1999-06-30 2001-01-31 Bechtel Bwxt Idaho, Llc Encapsulation method for maintaining biodecontamination activity
GB0005839D0 (en) * 2000-03-10 2000-05-03 Provita Eurotech Ltd Storage and delivery of micro-organisms
EP1509609B1 (fr) * 2002-06-04 2015-04-22 DSM IP Assets B.V. Hydrolysat de proteines riche en tripeptides
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
US20050180962A1 (en) * 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
US8377430B2 (en) * 2005-04-13 2013-02-19 Nestec S.A. Infant formula with probiotics
US20060233752A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
WO2006124630A2 (fr) * 2005-05-13 2006-11-23 New England Medical Center Hospitals, Inc. Compositions et procedes permettant d'augmenter l'efficacite de vaccins
US8697126B2 (en) * 2005-05-18 2014-04-15 Dsm Ip Assets B.V. Compositions for enternal application of microorganisms
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US20090203592A1 (en) * 2005-07-01 2009-08-13 N.V. Nutricia Infant nutrition with hydrolised proteins
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
US20070048295A1 (en) * 2005-08-23 2007-03-01 Ming-Ju Chen Method for preparing alginate capsules
WO2007036278A2 (fr) * 2005-09-29 2007-04-05 Merck Patent Gmbh Procede pour stabiliser des formes galeniques pharmaceutiques contenant des micro-organismes
US8524304B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
AU2005339139A1 (en) * 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
EP1832179B1 (fr) * 2005-12-20 2018-11-07 N.V. Nutricia Composition d'hydrates de carbone et réponse glycémique réduite
NL1032840C2 (nl) 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
CA2673120C (fr) * 2006-12-18 2012-08-07 Advanced Bionutrition Corporation Produit alimentaire sec contenant un probiotique vivant
BRPI0812647A2 (pt) * 2007-07-13 2014-09-30 Unilever Nv "composição e método para produzir a composição"
US10251899B2 (en) * 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
NZ597053A (en) * 2009-05-26 2014-02-28 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
JP2013514085A (ja) * 2009-12-18 2013-04-25 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド プロバイオティックを含むペットフード組成物ならびにそれを調製および使用する方法
US9504750B2 (en) * 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials

Also Published As

Publication number Publication date
CA2929168A1 (fr) 2015-06-11
AU2010295508B2 (en) 2016-08-04
CN105792676A (zh) 2016-07-20
JP2013505257A (ja) 2013-02-14
NZ718839A (en) 2021-09-24
CO6511231A2 (es) 2012-08-31
CN114128892A (zh) 2022-03-04
MX343446B (es) 2016-11-07
WO2015084531A1 (fr) 2015-06-11
US20110070334A1 (en) 2011-03-24
BR112012006220A2 (pt) 2017-06-06
CA2772534A1 (fr) 2011-03-24
CA2929168C (fr) 2022-01-04
AR098598A1 (es) 2016-06-01
JP6240386B2 (ja) 2017-11-29
TW201127955A (en) 2011-08-16
CN102573862A (zh) 2012-07-11
AU2014357609B2 (en) 2017-10-12
PH12016500689B1 (en) 2016-05-30
AU2010295508A1 (en) 2012-03-15
NZ598520A (en) 2014-02-28
PH12016500689A1 (en) 2016-05-30
ECSP12011820A (es) 2012-05-30
RU2012115658A (ru) 2013-10-27
CN107594537A (zh) 2018-01-19
EP2477638B1 (fr) 2018-07-25
MX2012002527A (es) 2012-04-11
US20140093613A1 (en) 2014-04-03
PE20121503A1 (es) 2012-11-09
TWI621707B (zh) 2018-04-21
ES2683310T3 (es) 2018-09-26
MX2016007007A (es) 2016-09-07
MY171199A (en) 2019-10-01
EP2477638A1 (fr) 2012-07-25
US20170296600A1 (en) 2017-10-19
WO2011035093A1 (fr) 2011-03-24
MY182617A (en) 2021-01-27
EP3079503A1 (fr) 2016-10-19
IN2012DN01440A (fr) 2015-06-05
KR20120068851A (ko) 2012-06-27
PL2477638T3 (pl) 2018-12-31
EP2477638A4 (fr) 2016-02-24
TW201531236A (zh) 2015-08-16

Similar Documents

Publication Publication Date Title
SG11201602868WA (en) Probiotic stabilization
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
EP2462514A4 (fr) Livre vert
EP2515891A4 (fr) 3-céto-n-propargyl-1-aminoindane
PL2464939T3 (pl) Udoskonalony nośnik przedmiotu obrabianego
GB0904835D0 (en) Trailersafe
GB0914596D0 (en) Improved hatchcover
DK2464943T3 (en) Systemintegration
GB0915809D0 (en) Fixarad
EP2510125A4 (fr) Hyperamorces
GB0910666D0 (en) Rowing-boat span-guages
AU4924P (en) Bonscablue Scaevola aemula
AU4926P (en) Bonscalib Scaevola aemula
AU4925P (en) Bonscawi Scaevola aemula
AU4240P (en) Tuckerbox xTriticosecale
GB0917038D0 (en) Clamp-it mate
AU328091S (en) Television
GB0916388D0 (en) Improved fly-hook
EG26256A (en) Oxygen hookah
GB201016598D0 (en) Enih
GB0912753D0 (en) Goal-flick
GB0900671D0 (en) Tugbug
GB0915439D0 (en) Photo2paint
GB0912142D0 (en) I-bliss